인쇄하기
취소

Ahngook Pharm’s osteoporosis treatment, ‘Binosto Effervescent Tab’ to be approved

Published: 2015-11-03 11:40:26
Updated: 2015-11-03 11:40:26

Ahngook Pharm(President Uh Jin) has completed domestic approval of Binosto Effervescent Tab(alendronate sodium 70mg), a bisphosphonate-type osteoporosis treatment, on Oct. 14.

Binosto Effervescent Tab is a novel improved drug in an effervescent type which was first developed by EffRx Pharmaceuticals(CEO Christer Rosen), a Swedish pharmaceutical company.

The domestic osteoporosis market, which...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.